Search

Your search keyword '"K Kaneko"' showing total 232 results

Search Constraints

Start Over You searched for: Author "K Kaneko" Remove constraint Author: "K Kaneko" Topic business Remove constraint Topic: business
232 results on '"K Kaneko"'

Search Results

1. Metal 3D-Printed 35–50-GHz Corrugated Horn for Cryogenic Operation

2. An Anti-HER2 Monoclonal Antibody H2Mab-41 Exerts Antitumor Activities in Mouse Xenograft Model Using Dog HER2-Overexpressed Cells

3. Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis

4. An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H2Mab-19 Exerts Antitumor Activity in Mouse Colon Cancer Xenografts

5. Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment

6. H2Mab-19 Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody Therapy Exerts Antitumor Activity in Pancreatic Cancer Xenograft Models

7. H2Mab‑19, an anti‑human epidermal growth factor receptor 2 monoclonal antibody exerts antitumor activity in mouse oral cancer xenografts

8. Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma

9. Generation and evaluation of a chimeric antibody against coxsackievirus and adenovirus receptor for cancer therapy

10. Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H2Mab-41 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer

11. Establishment of a Monoclonal Antibody PMab-231 for Tiger Podoplanin

12. Therapeutic efficacy evaluation of radioimmunotherapy with 90Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma

13. Abstract P4-14-07: Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 8–12 weeks' exemestane exposure for ER+/HER2– postmenopausal breast cancer patients

14. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

15. Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma

16. Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the 'Universal' CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2

17. Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin

18. Control system for the new RIKEN 28-GHz superconducting electron cyclotron resonance ion source for SRILAC

19. Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2

20. 47-mG2a: A Mouse IgG2a-Type of PcMab-47 Useful for Detecting Podocalyxin in Esophageal Cancers by Immunohistochemistry

21. LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer

22. Anti-Podocalyxin Monoclonal Antibody 47-mG2a Detects Lung Cancers by Immunohistochemistry

23. Sphincter-preserving surgery for recurrent pelvic malignancy using a hybrid procedure of open laparotomy and transanal endoscopic approach

24. Abstract P3-13-06: Tailored neoadjuvant endocrine and chemo-endocrine therapy for postmenopausal patients with estrogen receptor-positive human epidermal growth factor receptor 2-negative primary breast cancer

25. Immunohistochemical Analysis of Inflammatory Rheumatoid Synovial Tissues Using Anti-Human Podoplanin Monoclonal Antibody Panel

26. Development of an Anti-HER2 Monoclonal Antibody H2Mab-139 Against Colon Cancer

27. European Society for Clinical Nutrition and Metabolism (ESPEN) Malnutrition Criteria for Predicting Major Complications after Hepatectomy and Pancreatectomy

28. Establishment of H2Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer

29. H2Mab-77 is a Sensitive and Specific Anti-HER2 Monoclonal Antibody Against Breast Cancer

30. 180P Development of prognosis prediction model using cytokeratin 19 mRNA copy number of sentinel lymph node metastasis in breast cancer: A multicenter study in Japan

31. Treatment of finger phalangeal fractures using the Ichi-Fixator system: A prospective study of 12 cases

32. Spontaneous recovery from suppressed B cell production and proliferation caused by intrauterine azathioprine exposure in the fetal period

33. Anti-CD133 Monoclonal Antibody CMab-43 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer

34. Anti-podoplanin antibody against MPM

36. Inferior pancreaticoduodenal artery pseudoaneurysm rupture caused by the pancreatic neuroendocrine tumor: a case report

37. Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation

38. P289Comparison of long DAPT versus short DAPT in Japanese PCI patients based on healthcare information database

41. Differentiation of chromophobe renal cell carcinoma and renal oncocytoma with whole-lesion ADC analysis on diffusion-weighted MRI

42. An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas

43. The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity

44. Tuning Circuit Material for Mass-Produced Terahertz SIS Receivers

45. Expression of Cat Podoplanin in Feline Squamous Cell Carcinomas

46. ALMA band 2+ (67–95 GHz) receiver optics

49. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis

50. Abstract B098: A novel monoclonal antibody for a cancer stem cell marker CD133 exerts antitumor and antimetastasis activities for colon cancers

Catalog

Books, media, physical & digital resources